Literature DB >> 21133884

Lymphocyte subset reconstitution after unrelated cord blood or bone marrow transplantation in children.

Cécile Rénard1, Vincent Barlogis, Valérie Mialou, Claire Galambrun, Delphine Bernoux, Marie Pierre Goutagny, Laurence Glasman, Anderson Dieudonné Loundou, Françoise Poitevin-Later, Françoise Dignat-George, Valérie Dubois, Christophe Picard, Christian Chabannon, Yves Bertrand, Gérard Michel.   

Abstract

We report the post-transplant lymphocyte subset recovery of 226 children treated with Unrelated Cord Blood transplant (UCBT) (n = 112) or Unrelated Bone Marrow Transplant (UBMT) (n = 114) for malignant or non-malignant diseases. Absolute numbers of natural killer (NK), B and T cells were monitored by flow cytometry up to 5 years post-transplant. Immunological endpoints were: time to achieve a CD3(+) cell count > 0·5 and 1·5 × 10⁹/l, CD4(+) > 0·2 and 0·5 × 10⁹/l, CD8(+) > 0·25 ×10⁹/l, CD19(+) > 0·2 × 10⁹/l, NK > 0·1 × 10⁹/l. These endpoints were analysed through the use of cumulative incidence curves in the context of competing risks. CD8(+) T cell recovery was delayed after UCBT with a median time to reach CD8(+) T cells > 0·25 × 10⁹/l of 7·7 months whereas it was 2·8 months in UBMT (P < 0·001). B cell recovery was better in UCBT, with a median time to reach CD19(+) cells > 0·2 × 10⁹/l of 3·2 months in UCBT and 6·4 months in UBMT (P = 0·03). Median time for CD4(+) T cell and NK cell recovery was similar in UCBT and UBMT. CD4(+) T cells recovery was negatively correlated to age (better reconstitution in younger patients, P = 0·002). CD8(+) T cells recovery was shorter in recipients with a positive cytomegalovirus serology (P =0·001).
© 2010 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21133884     DOI: 10.1111/j.1365-2141.2010.08409.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  21 in total

Review 1.  Reconstitution of adaptive immunity after umbilical cord blood transplantation: impact on infectious complications.

Authors:  Sophie Servais; Muriel Hannon; Régis Peffault de Latour; Gérard Socie; Yves Beguin
Journal:  Stem Cell Investig       Date:  2017-05-25

2.  Cytomegalovirus-specific T cells are primed early after cord blood transplant but fail to control virus in vivo.

Authors:  Suzanne M McGoldrick; Marie E Bleakley; Abraham Guerrero; Cameron J Turtle; Tori N Yamamoto; Shalini E Pereira; Colleen S Delaney; Stanley R Riddell
Journal:  Blood       Date:  2013-02-14       Impact factor: 22.113

3.  Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.

Authors:  Rachel J Bergerson; Robin Williams; Hongbo Wang; Ryan Shanley; Gretchen Colbenson; Alyssa Kerber; Sarah Cooley; Julie Curtsinger; Martin Felices; Jeffrey S Miller; Michael R Verneris
Journal:  Blood Adv       Date:  2016-10-30

4.  NCI, NHLBI/PBMTC first international conference on late effects after pediatric hematopoietic cell transplantation: persistent immune deficiency in pediatric transplant survivors.

Authors:  Nancy Bunin; Trudy Small; Paul Szabolcs; K Scott Baker; Michael A Pulsipher; Troy Torgerson
Journal:  Biol Blood Marrow Transplant       Date:  2011-11-17       Impact factor: 5.742

5.  A novel reduced-intensity conditioning regimen for unrelated umbilical cord blood transplantation in children with nonmalignant diseases.

Authors:  Suhag H Parikh; Adam Mendizabal; Cara L Benjamin; Krishna V Komanduri; Jeyaraj Antony; Aleksandra Petrovic; Gregory Hale; Timothy A Driscoll; Paul L Martin; Kristin M Page; Ketti Flickinger; Jerelyn Moffet; Donna Niedzwiecki; Joanne Kurtzberg; Paul Szabolcs
Journal:  Biol Blood Marrow Transplant       Date:  2013-12-01       Impact factor: 5.742

6.  Immunologic recovery in children after alternative donor allogeneic transplantation for hematologic malignancies: comparison of recipients of partially T cell-depleted peripheral blood stem cells and umbilical cord blood.

Authors:  Benjamin R Oshrine; Yimei Li; David T Teachey; Jennifer Heimall; David M Barrett; Nancy Bunin
Journal:  Biol Blood Marrow Transplant       Date:  2013-08-11       Impact factor: 5.742

Review 7.  The role of the thymus in T-cell immune reconstitution after umbilical cord blood transplantation.

Authors:  Ioannis Politikos; Vassiliki A Boussiotis
Journal:  Blood       Date:  2014-10-06       Impact factor: 22.113

Review 8.  New frontiers in pediatric Allo-SCT.

Authors:  J M Talano; M A Pulsipher; H J Symons; O Militano; E B Shereck; R H Giller; L Hancock; E Morris; M S Cairo
Journal:  Bone Marrow Transplant       Date:  2014-05-12       Impact factor: 5.483

9.  Prevention of graft-versus-host disease by adoptive T regulatory therapy is associated with active repression of peripheral blood Toll-like receptor 5 mRNA expression.

Authors:  Birgit Sawitzki; Claudio Brunstein; Christian Meisel; Julia Schumann; Katrin Vogt; Christine Appelt; Julie M Curtsinger; Michael R Verneris; Jeffrey S Miller; John E Wagner; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2013-11-01       Impact factor: 5.742

Review 10.  Immune function in childhood cancer survivors: a Children's Oncology Group review.

Authors:  Gregory M T Guilcher; Linda Rivard; Jennifer T Huang; Nicola A M Wright; Lynette Anderson; Hesham Eissa; Wendy Pelletier; Shanti Ramachandran; Tal Schechter; Ami J Shah; Ken Wong; Eric J Chow
Journal:  Lancet Child Adolesc Health       Date:  2021-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.